Treatment decision making and psychosocial outcomes associated with rapid genetic testing for BRCA1 and BRCA2 in women newly diagnosed with breast cancer

被引：2
|
作者：
Metcalfe, Kelly A.
Narod, Steven
Eisen, Andrea
Lerner-Ellis, Jordan
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Womens Coll Res Inst, Toronto, ON, Canada
[3] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[4] Mt Sinai Hosp, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.1586
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1586
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Development and Testing of a Decision Aid for Unaffected Women with a BRCA1 or BRCA2 Mutation
    Terri Jabaley
    Meghan L. Underhill-Blazey
    Donna L. Berry
    Journal of Cancer Education, 2020, 35 : 339 - 344
  • [42] Genetic heterogeneity in hereditary breast cancer: Role of BRCA1 and BRCA2
    Rebbeck, TR
    Couch, FJ
    Kant, J
    Calzone, K
    DeShano, M
    Peng, Y
    Chen, K
    Garber, JE
    Weber, BL
    AMERICAN JOURNAL OF HUMAN GENETICS, 1996, 59 (03) : 547 - 553
  • [43] Compliance With Tamoxifen in Women With Breast Cancer and a BRCA1 or BRCA2 Mutation
    Narod, Steven A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : E698 - E699
  • [44] Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
    Lu Yao
    Jie Sun
    Juan Zhang
    Yingjian He
    Tao Ouyang
    Jinfeng Li
    Tianfeng Wang
    Zhaoqing Fan
    Tie Fan
    Benyao Lin
    Yuntao Xie
    Breast Cancer Research and Treatment, 2016, 156 : 441 - 445
  • [45] Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations
    Rennert, Gad
    Bisland-Naggan, Shantih
    Barnett-Griness, Ofra
    Bar-Joseph, Naomi
    Zhang, Shiyu
    Rennert, Hedy S.
    Narod, Steven A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (02): : 115 - 123
  • [46] Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations
    Metcalfe, Kelly A.
    WOMENS HEALTH, 2009, 5 (01) : 63 - 68
  • [47] Recurrent BRCA1 and BRCA2 Mutations in Mexican Women with Breast Cancer
    Torres-Mejia, Gabriela
    Royer, Robert
    Llacuachaqui, Marcia
    Akbari, Mohammad R.
    Giuliano, Anna R.
    Martinez-Matsushita, Louis
    Angeles-Llerenas, Angelica
    Ortega-Olvera, Carolina
    Ziv, Elad
    Lazcano-Ponce, Eduardo
    Phelan, Catherine M.
    Narod, Steven A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (03) : 498 - 505
  • [48] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Kotsopoulos, Joanne
    Gronwald, Jacek
    Huzarski, Tomasz
    Aeilts, Amber
    Armel, Susan Randall
    Karlan, Beth
    Singer, Christian
    Eisen, Andrea
    Tung, Nadine
    Olopade, Olufunmilayo
    Bordeleau, Louise
    Eng, Charis
    Foulkes, William
    Neuhausen, Susan
    Cullinane, Carey
    Pal, Tuya
    Fruscio, Robert
    Lubinski, Jan
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 257 - 264
  • [49] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Joanne Kotsopoulos
    Jacek Gronwald
    Tomasz Huzarski
    Amber Aeilts
    Susan Randall Armel
    Beth Karlan
    Christian F. Singer
    Andrea Eisen
    Nadine Tung
    Olufunmilayo Olopade
    Louise Bordeleau
    Charis Eng
    William D. Foulkes
    Susan L. Neuhausen
    Carey A. Cullinane
    Tuya Pal
    Robert Fruscio
    Jan Lubinski
    Kelly Metcalfe
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2023, 201 : 257 - 264
  • [50] Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
    Yao, Lu
    Sun, Jie
    Zhang, Juan
    He, Yingjian
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 441 - 445
12345